Anti-inflammatory effects of high-density lipoprotein through activating transcription factor 3: benefit beyond cholesterol transport-dependent processes

Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):e11-2. doi: 10.1161/ATVBAHA.114.303553. Epub 2014 Apr 17.

Authors

Hanrui Zhang¹, Muredach P Reilly²

Affiliations

¹ From the Department of Medicine, Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
² From the Department of Medicine, Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. muredach@mail.med.upenn.edu.

No abstract available

Keywords: HDL cholesterol; commentary; inflammation.

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Activating Transcription Factor 3 / metabolism*
Animals
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Atherosclerosis / therapy*
Cholesterol / metabolism*
Female
Humans
Inflammation / therapy*
Lipoproteins, HDL / therapeutic use*
Macrophages / drug effects*

Substances

Activating Transcription Factor 3
Anti-Inflammatory Agents, Non-Steroidal
Lipoproteins, HDL
Cholesterol

Grants and funding